Jacobs Levy Equity Management’s Minerva Neurosciences NERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-60,893
Closed -$848K 1044
2021
Q3
$848K Sell
60,893
-27,239
-31% -$379K 0.01% 778
2021
Q2
$1.64M Sell
88,132
-6,512
-7% -$121K 0.01% 639
2021
Q1
$2.21M Buy
94,644
+20,965
+28% +$490K 0.02% 578
2020
Q4
$1.38M Buy
73,679
+21,291
+41% +$398K 0.01% 651
2020
Q3
$1.33M Buy
52,388
+20,111
+62% +$512K 0.01% 600
2020
Q2
$932K Sell
32,277
-2,446
-7% -$70.6K 0.01% 681
2020
Q1
$1.67M Sell
34,723
-12,057
-26% -$581K 0.02% 519
2019
Q4
$2.66M Buy
46,780
+41,957
+870% +$2.39M 0.03% 494
2019
Q3
$299K Sell
4,823
-18,216
-79% -$1.13M ﹤0.01% 775
2019
Q2
$1.04M Buy
23,039
+6,493
+39% +$293K 0.01% 638
2019
Q1
$1.04M Buy
16,546
+5,987
+57% +$376K 0.02% 652
2018
Q4
$569K Sell
10,559
-750
-7% -$40.4K 0.01% 713
2018
Q3
$1.14M Buy
11,309
+4,963
+78% +$498K 0.02% 628
2018
Q2
$419K Buy
6,346
+184
+3% +$12.1K 0.01% 835
2018
Q1
$308K Buy
6,162
+3,324
+117% +$166K 0.01% 865
2017
Q4
$137K Buy
+2,838
New +$137K ﹤0.01% 939
2017
Q3
Sell
-3,563
Closed -$252K 1003
2017
Q2
$252K Hold
3,563
0.01% 797
2017
Q1
$231K Hold
3,563
﹤0.01% 769
2016
Q4
$335K Sell
3,563
-957
-21% -$90K 0.01% 748
2016
Q3
$510K Sell
4,520
-150
-3% -$16.9K 0.01% 714
2016
Q2
$381K Buy
+4,670
New +$381K 0.01% 828
2016
Q1
Sell
-1,990
Closed -$97K 1160
2015
Q4
$97K Buy
+1,990
New +$97K ﹤0.01% 741
2015
Q3
Sell
-3,925
Closed -$182K 850
2015
Q2
$182K Buy
+3,925
New +$182K ﹤0.01% 734